Key facts
Consultation rates for respiratory illness in both primary and secondary care remain at low or baseline levels in all reporting EU/EEA countries. However, rates are increasing in many countries.
Both SARS-CoV-2 and influenza are contributing to respiratory virus activity in primary and secondary care this week, with median test positivity of 5.6% for SARS-CoV-2 and 4.0% for influenza in primary care, and 8.1% and 9.1%, respectively, in secondary care.
- SARS-CoV-2 test positivity remains low in primary and secondary care across most countries, with two countries reporting higher test positivity. However, increasing numbers of SARS-CoV-2 detections are being reported through laboratory-based surveillance systems in both primary and secondary care settings. Most detections in secondary care are reported among adults aged over 65 years.
- Influenza virus activity is at baseline or low levels overall. Low numbers of influenza detections are reported in both primary and secondary care settings. Most detections in secondary care are among adults aged over 65 years, predominantly influenza A viruses.
- Respiratory syncytial virus (RSV) activity is very low.
Overview
ECDC monitors respiratory illness rates and virus activity across the EU/EEA. Findings are presented in the European Respiratory Virus Surveillance Summary (ERVISS.org), which is updated weekly.
Key visualisation from the weekly bulletin are included below.
All data are provisional and may be affected by reporting delays, incomplete country data or low testing volumes. A few countries with high testing rates can disproportionately influence pooled data. Further information is available under ‘Country notes’ and ‘Additional resources’.
